Figure 1.

Domain architecture of NSD2 and chemical evolution of NSD2-PWWP1 antagonists. Receptor-based virtual screening followed by target and scaffold hopping led to the development of 3.

Domain architecture of NSD2 and chemical evolution of NSD2-PWWP1 antagonists. Receptor-based virtual screening followed by target and scaffold hopping led to the development of 3.